πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 14 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12364775

Viral vectors for cancer therapy

Krystal Biotech, Inc. Β· Granted Tue Jul 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12128122

Recombinant nucleic acids encoding cosmetic protein(s) for aesthetic

Krystal Biotech, Inc. Β· Granted Tue Oct 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11918660

Viral vectors for cancer therapy

Krystal Biotech, Inc. Β· Granted Tue Mar 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11865148

Methods of delivering transgenes to the eye

Krystal Biotech, Inc. Β· Granted Tue Jan 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11779660

Viral vectors for cancer therapy

Krystal Biotech, Inc. Β· Granted Tue Oct 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11717547

Compositions and methods for the treatment of autosomal recessive congenital ichthyosis

Krystal Biotech, Inc. Β· Granted Tue Aug 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 03 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11642384

Compositions and methods for the treatment of Netherton Syndrome

Krystal Biotech, Inc. Β· Granted Tue May 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11185564

Compositions and methods for the treatment of wounds, disorders, and diseases of the skin

Krystal Biotech, Inc. Β· Granted Tue Nov 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10829529

Compositions and methods for delivering CFTR polypeptides

Krystal Biotech, Inc. Β· Granted Tue Nov 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10786438

Recombinant nucleic acids encoding cosmetic protein(s) for aesthetic applications

Krystal Biotech, Inc. Β· Granted Tue Sep 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 24 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10525090

Compositions and methods for the treatment of autosomal recessive congenital ichthyosis

Krystal Biotech, Inc. Β· Granted Tue Jan 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10441614

Compositions and methods for the treatment of wounds, disorders, and diseases of the skin

Krystal Biotech, Inc. Β· Granted Tue Oct 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10155016

Compositions and methods for the treatment of wounds, disorders, and diseases of the skin

Krystal Biotech, Inc. Β· Granted Tue Dec 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9877990

Compositions and methods for the treatment of wounds, disorders, and diseases of the skin

Krystal Biotech, Inc. Β· Granted Tue Jan 30 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 25 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted